Anatomic Pathology Market - Global Market Share, Trends, Analysis and Forecast 2023 – 2032
The anatomic pathology market was valued at US$ 21.9 billion in 2021 and is expected to grow at a CAGR of 6.1% through 2032.
Anatomic Pathology is a specialty branch of medicine which involves diagnosis of the diseases based on the macroscopic, microscopic, and immunologic and the microscopic examination of the organs and the tissues. In short, it is the study of the different tissues which is required to determine certain causes and effects of the particular diseases.
It involves the detailed examination of the human tissue under a microscopic lens for the proper diagnosis of the disease or a pathological condition. The microscopic examination is one of the standard procedures under the anatomic pathological examination.
Market Forecast for the anatomic pathology market
Anatomic pathology market is expected to witness rapid growth due to the rise in the incidence of cancer and other diseases. There has been an increased focus on personalized medicine along with several significant government support programs and several training modules for the government. This leads to increased demand for anatomic pathology. Due to rise in the lifestyle disorders and chronic diseases, there has been a rapid level of testing in the pathology labs along with the procedures of staining systems, gross imaging, and digital microscopes which are known to increase the anatomic pathological practices to a significant extent. The increase in the patient pool along with the growing awareness among the patient is also a strong factor in the rise in anatomic pathology market.
The major market drivers
The high prevalence of cancer especially in the developed countries will most likely propel the demand for the anatomic pathology market. However, it is also observed that cancer mortality is the highest among the people in the under-developed countries, due to the lack of treatment and lack of testing facilities in the countries. Anatomic products are used in several oncology drug trials to understand quantitative information, detect the morphological structures and also understand the different drug mechanisms.
Global Anatomic Pathology Market- Share Analysis, by Geography (2021)
The report titled “Global Anatomic Pathology Market- Global Market Share, Trends, Analysis and Forecasts, 2022-2032” offers market estimates for a period 2022 to 2032, wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Anatomic Pathology Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
North America is expected to be the highest revenue generator for anatomic pathology market; the reason being many competitive players and several government initiatives about the training of the pathological programs. In North America region, there is also easy accessibility to the advanced technologies, the increased healthcare expenditure, and the presence of high-quality infrastructure hospitals and several clinical laboratories in the region.
The Top Industry players include F Hoffman La Roche, Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Bio SB, BioGenex Laboratories among others.
The report on the anatomic pathology market presents an analytical depiction of the industry along with the current trends, market drives, and growth opportunities in the market.
Market segmentation
By Product Type
- Histopathology
- Cytopathology
By Application
- Diseases Diagnostic
- Cancer screening and detection
- Other diseases
- Medical Research
By End-user
- Hospital Laboratories
- Clinical Laboratories
- Others
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
Frequently asked questions about this report
How big is the Anatomic Pathology Market?
The Anatomic Pathology market was worth US$ 21.9 billion in 2021.
What is the CAGR of the anatomic pathology market?
The Anatomic Pathology market is estimated to exhibit a CAGR of 6.1% by 2032.
Who are the major players offering anatomic pathology in the market?
F Hoffman La Roche, Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Bio SB, BioGenex Laboratories among others are the major key players in the global anatomic pathology market.
What are the market drivers for anatomic pathology market?
The high prevalence of cancer especially in the developed countries will most likely propel the demand for the anatomic pathology market and due to the lack of treatment and lack of testing facilities in the countries.
What are anatomic pathology market opportunities?
Key anatomic pathology market opportunities include a growing focus on tissue base diagnostic procedures and the emergence of automated systems in the market space.
Which region dominates the anatomic pathology market?
Due to a large number of rival companies and numerous government initiatives regarding the education of diagnostic programs, North America is anticipated to provide the highest level of revenue for the anatomic pathology market.